Dr. Barbara Ludmila Nye, MD

Dr. Nye practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Nye's NPI, 1083933790, was assigned on May 19, 2010. Dr. Nye graduated from University of South Florida College of Medicine in 2010. Dr. Nye holds North Carolina license 2021-02943.

Dr. Nye's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Nye's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Nye is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Nye to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nye practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nye's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Nye's licenses on file in 2 states: North Carolina and New Hampshire.

CMS data shows 270 Medicare services from Dr. Nye across 8 procedure codes in 2024, for 80 Medicare patients. Medicare paid $14,365 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Nye in 2024. The largest group is 65 to 74, with 35 patients. 73% of them have high cholesterol, and 69% have arthritis. 19% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nye's median patient age at 57, with 75% women.

In 2024, Dr. Nye wrote 865 Medicare Part D claims for 102 patients. 69% of them were for generic drugs. CMS names the drug for 701 of them, across 25 drugs with 11 or more claims each, at $219,410 in total drug cost. In 2023, CMS named 375 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Nye for performance year 2024, reported as part of a group. Dr. Nye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nye as offering telehealth.

Dmand AI links 6 papers to Dr. Nye, published from 2015 to 2022. 2015 was the busiest year, with 2. The most frequent topics are Migraine Disorders and Epilepsy. Dr. Nye has published most often in Headache. Dr. Nye's most frequent co-authors are Vijay M. Thadani, MD, Sait Ashina, MD and Stephanie Ann Coffman, MD.

Dmand AI links Dr. Nye to 5 clinical trials, 2 of them phase 3 studies. Conditions studied include Cluster Headache, Migraine without Aura and Migraine with Aura. Satsuma Pharmaceuticals, Inc. sponsors the most, 2.

CMS Open Payments shows 56 general payments to Dr. Nye from 13 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 50% of the total. Amneal Pharmaceuticals LLC paid the most, $8,700. It also lists 3 research payments totaling $1,102 from 2016 to 2019.

Dr. Nye graduated from University of South Florida College of Medicine in 2010.